510(k) device
Protime Microcoagulation System / Protime 3 Cuvette
International Technidyne Corp. · Test, Time, Prothrombin (GJS, Class II) · First FDA decision Jul 2, 2001, newest Jul 2, 2001Anemia, clotting and blood disordersStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Protime Microcoagulation"
MAUDE reports
3
Brand "Protime Microcoagulation", since 2015
PubMed studies
5
Mentioning "Protime Microcoagulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Protime Microcoagulation System / Protime 3 Cuvette
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K010599 · Decided Jul 2, 2001 · 124 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNational determinationOn the books190.11Updated Nov 4, 2026
- Prothrombin Time (PT)National determinationOn the books190.17Updated Oct 1, 2026
- Prothrombin Time (INR) Monitor for Home Anticoagulation ManagementNational analysisReview closedCAG-00087RUpdated Sep 21, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)Coding analysisReview closedCAG-00201NUpdated Sep 15, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)Coding analysisReview closedCAG-00184NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
- Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)Coding analysisReview closedCAG-00404NUpdated Sep 15, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Protime Microcoagulation", any status and sponsor, newest update first.
No registered device study names "Protime Microcoagulation".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Protime Microcoagulation", and for the whole product code for context.
This brand
3 reports: 3 malfunction, 0 injury, 0 death
Whole product code GJS
12,207 reports: 11,507 malfunction, 644 injury, 34 death
Newest reports for this brand
INTERNATIONAL TECHNIDYNE CORP.
2248721-2015-00031 · Received May 22, 2015 · Event dated Apr 23, 2015
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Low Test Results
Patient problem as coded: No Known Impact Or Consequence To Patient
INTERNATIONAL TECHNIDYNE CORP.
2248721-2015-00030 · Received May 22, 2015 · Event dated Apr 23, 2015
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Low Test Results
Patient problem as coded: No Known Impact Or Consequence To Patient
- PROTIME MICROCOAGULATION SYSTEMMalfunction
INTERNATIONAL TECHNIDYNE CORP.
2248721-2014-00060 · Received Jan 27, 2015 · Event dated Dec 31, 2014
Device type: Instrument, Coagulation, Automated (GKP)
Device problem as coded: Low Test Results
Patient problem as coded: No Known Impact Or Consequence To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2198-2013 · Started Jul 16, 2013 · Posted by FDA Sep 13, 2013
Reason given: The products may have been stored at temperatures outside their required storage conditions.
Cause as FDA categorized it: Storage · Device type: Test, Time, Prothrombin (GJS)
International Technidyne Corp.
Z-0837-2013 · Started Sep 28, 2012 · Posted by FDA Feb 19, 2013
Reason given: Some Pro Time3 Test Cuvettes within a specified lot range may recover lower than expected Prothrombin Time/International Normalized Ratio (PT/INR) results.
Cause as FDA categorized it: Process change control · Device type: Test, Time, Prothrombin (GJS)
International Technidyne Corporation
Z-0546-2008 · Started Nov 19, 2007 · Posted by FDA Jan 25, 2008
Reason given: An increase in the frequency of non-conformance reports (NCMR) for certain displayed error messages.
Cause as FDA categorized it: Device Design · Device type: Test, Time, Prothrombin (GJS)
Published research
The most relevant PubMed records for "Protime Microcoagulation"[tiab]. The summary above synthesizes these.
- Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting.
Chapman DC, Stephens MA, Hamann GL, et al. · Ann Pharmacother · 1999Clinical Trial, Comparative Study
- Whole blood international normalization ratio measurements in children using near-patient monitors.
Nowatzke WL, Landt M, Smith C, et al. · J Pediatr Hematol Oncol · 2003Comparative Study
- A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
Gosselin R, Owings JT, White RH, et al. · Thromb Haemost · 2000Comparative Study
- The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation.
Sharma P, Scotland G, Cruickshank M, et al. · Health Technol Assess · 2015Research Support, Non-U.S. Gov't, Systematic Review
- Preparation of control blood for external quality assessment of point-of-care international normalized ratio testing in the Netherlands.
van den Besselaar AM, Abdoel CF, Ardanary D, et al. · Am J Clin Pathol · 2014Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code GJS.
- microINR SystemIline Microsystems, S.L. · 510(k) 2025
- CoaguChek XS Plus SystemRoche Diagnostics · 510(k) 2025
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc. · 510(k) 2022
- CoaguChek XS Pro SystemRoche Diagnostics · 510(k) 2018
- Hemosil Recombiplastin 2G (8 Ml Vial)Instrumentation Laboratory CO · 510(k) 2014
- Coaguchek Xs SystemRoche Diagnostics Corp. · 510(k) 2007
- Xprecia Prime Coagulation SystemUniversal Biosensors Pty, Ltd. · 510(k) 2024
- i-STAT PTplus Cartridge with the i-STAT 1 SystemAbbott Laboratories · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.